UPDATE 1-Early data promising for AstraZeneca cancer drug combination

September 27, 2014 11:47 AM

16 0

* Objective response rate in patients 28 percent (Adds comments from researcher, paragraphs 5 and 11)

MADRID, Sept 27 (Reuters) - Early results for a closely watched cancer drug combination from AstraZeneca that boosts the immune system show the cocktail is promising, though limited patient numbers mean the data is far from conclusive.

Read more

To category page